Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Pelvic Floor Stimulators Market Snapshot

As per the recent report by FMI, global sales of the pelvic floor stimulators industry are projected to total US$ 140.39 million for 2023. The demand outlook for the market remains buoyant as FMI forecasts it to exhibit a CAGR of 8.8% from 2023 to 2033, reaching US$ 325.41 million by 2033.

The market growth in being induced by the following factors:

  • Increasing cases of urinary incontinence
  • Growing awareness campaigns by different governments and NGOs across the globe
  • Constant technical advances in the pelvic floor stimulators
  • The high pervasiveness of neurodegenerative diseases
  • The rapidly increasing base of the senior population
  • Emergence and convenience of home healthcare
  • Surging utilization of medical sensors in diverse treatments
Attribute Details
Pelvic Floor Stimulators Market Size (2023) US$ 140.39 million
Pelvic Floor Stimulators Market Size (2033) US$ 325.41 million
Pelvic Floor Stimulators Forecast CAGR (2023 to 2033) 8.8%
Pelvic Floor Stimulators Market Size (2022) US$ 129.04 million
Pelvic Floor Stimulators Historical CAGR (2018 to 2022) 4.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Opportunities Can Manufacturers Leverage Through Telehealth?

Adopting telehealth facilities for pelvic floor care is expected to create attractive opportunities for manufacturers. The advent of telemedicine has improved access to care, enhanced resource productivity, and reduced costs related to traditional office visits in a wide array of medical fields.

Top healthcare institutes are adopting telehealth for patients' convenience to discuss pelvic floor dysfunction problems and other related disorders. With telehealth, HCPs could interact with patients sequestered in their homes. Hospitals like UCLA are now focusing on teleconsultation to reach people to provide support.

What are the Factors Restraining Demand for Pelvic Floor Stimulators?

Despite urinary incontinence's social and financial burden, fewer than half of women with significant PFD symptoms pursue treatment. Besides this, women often feel personal embarrassment, unaware that PFDs are medical conditions and that treatment options exist. A lack of awareness is expected to continue restraining growth in the market.

Similarly, inadequate reimbursement policies in countries with poor economies are projected to hinder market growth. Insurance payers are reluctant to cover PFDs as the treatment mainly covers physical therapy. Some insurers consider physical therapy medically necessary with a provider referral.

Other insurers place a cap on visits they are going to cover per year. Affordability is a significant problem for a considerable chunk of the population due to the absence of health insurance and government support policies that cover treatment in developing countries such as India and China. This absence of social health insurance and the exclusionary provision of private health insurance schemes significantly limit the pelvic floor stimulators industry.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

2018 to 2022 Pelvic Floor Stimulators Market Outlook Compared to 2023 to 2033 Forecast

FMI predicts the pelvic floor stimulator sales to record a surge at 8.8% CAGR between 2023 and 2033 as against sales growth of 4.8% registered in 2018 to 2022. Demand is projected to continue rising in response to the surging cases of urinary incontinence around the world.

According to sources from the National Association for Continence (NAFC), around 200 million adults are suffering from some form of urinary incontinence worldwide. It further states that the condition is more common in women and says that the United States accounts for 25 million adult patients, up to 80% being women.

Similarly, the growing incidence of diabetes and hypertension is a significant factor in the increase of patients suffering from urinary incontinence. This, in turn, is driving the demand for pelvic floor stimulators. FMI has predicted the demand for female stress urinary incontinence treatment devices to gain considerable momentum in the near future. This is projected to, in turn, present opportunities for pelvic floor stimulator market players to capitalize on.

According to a report published by the World Health Organization (WHO) in 2019, about 1.13 billion people have hypertension. Diabetes is the leading cause of advanced renal failure, followed by hypertension, which affects about one billion people worldwide.

Pelvic floor stimulators are often administered to offer advanced care to patients suffering from end-stage renal diseases. FMI sees this as a chief growth driver of the market. Coupled with this, technological advancements reported in the healthcare sector, besides the rising emphasis on non-invasive treatments, are projected to pave the way for the expansion of the market in the coming years.

Non-invasive treatments also stimulate muscle pathways and nerves without requiring active patient involvement, which is expected to drive the demand during the forecast period.

New products are being integrated with Bluetooth to connect with smartphones for real-time progress tracking without the risks of surgery or adverse effects associated with treatment. In February 2020, Atlantic Therapeutics (Ireland) received clearance from the FDA, allowing the wearable electric muscle stimulator device to be sold over the counter for treating stress urinary incontinence.

These developments are projected to remain crucial for the market, enabling pelvic floor stimulator manufacturers to up their game in the coming years.

Comparative View of the Pelvic Floor Stimulators Market

Pelvic Floor Stimulators Market:

Attributes Pelvic Floor Stimulators Market
CAGR (2023 to 2033) 8.8%
Market Value (2033) US$ 325.41 million
Opportunity Surging emphasis on first-line conservative management programs for women dealing with urinary incontinence is expected to be beneficial for the market.
Key Trends Growing utilization of electrical stimulation is one of the advanced types of biofeedback for pelvic floor muscle rehabilitation in developed countries.

Female Pelvic Implants Market:

Attributes Female Pelvic Implants Market
CAGR (2023 to 2033) 2.8%
Market Value (2033) US$ 340.92 million
Opportunity The female pelvic floor reconstruction process is projected to be revolutionized by the introduction of novel tissue engineering.
Key Trends Constant post-marketing surveillance of permitted devices is expected to propel the market.

Urinary Tract Infection (UTI) Treatment Market:

Attributes Urinary Tract Infection (UTI) Treatment Market
CAGR (2023 to 2033) 2%
Market Value (2033) US$ 13.46 billion
Opportunity The rising incidence of chronic kidney diseases and cancer led to an increase in the usage of catheters. Therefore, the need for a less complicated urethral catheter design to prevent blockage and irritation drives the market growth.
Key Trends The surging release of a government-approved intervention plan for the reproductive health of females is the key market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

What Factors Support Sales of Pelvic Floor Stimulators in the United States?

The United States holds over 76% share of the North America pelvic floor stimulators industry. As per the Department of Health and Human Services of the United States, urinary incontinence is observed to be twice as common among women when compared with men.

This can be attributed to childbirth, pregnancy, and menopause. Urinary incontinence is not a normal part of aging and can be treated. Over the last decade, electrical stimulation has developed as one of the most advanced and unique types of biofeedback that can be used for pelvic floor muscle rehabilitation in the United States.

The growing inclination toward research and development is to find a cost-effective and efficient pelvic floor exercise method. Moreover, the rising focus on first-line conservative management programs for women suffering from urinary incontinence is a significant factor likely to fuel the adoption of pelvic floor stimulators in the United States.

How is the Pelvic Floor Stimulators Market Faring in the United Kingdom?

Country The United Kingdom
Forecast CAGR (2023 to 2033) 8.7%

The United Kingdom accounts for over 25% share of the Europe market through the assessment period ending in 2033. The high prevalence of urinary incontinence, the surge in the adoption of technologically advanced products, a large base of medical device companies, and a massive pipeline of products drive demand.

The market in the United Kingdom is likely to expand at a high CAGR of 8.7% during the forecast period. Around 6 million people in the United Kingdom are suffering from urinary incontinence, according to the National Health Service (2017).

What is the Scope of Growth for Pelvic Floor Stimulator Production in India?

The Indian market accounts for more than 55% of the sales registered in South Asia in 2022. Various factors, such as growing investment by leading players, increasing government spending, and awareness programs by several government and non-government organizations, are driving the market growth.

The Urological Society of India enlisted guidelines for increasing awareness about urinary incontinence in the country. Furthermore, increasing healthcare expenditure due to the pandemic has created a greater scope for adoption. The growing population makes it a promising market in the coming years.

What Factors are Driving Revenue Generation in the Australia Market?

Country Australia
Forecast CAGR (2023 to 2033) 10.6%

The market for pelvic floor stimulators in Australia is exhibiting a 10.6% CAGR and is projected to account for more than 83% of the Oceania market throughout the projection period. Increasing government initiatives to create awareness is anticipated to boost regional market growth.

The Australian government has developed the Continence Aids Payment Scheme (CAPS) to support patients with severe incontinence problems with their needs. They have also launched National Continence Management Program to increase awareness about numerous bowel and bladder health problems.

Moreover, urologists, urogynecologists, gynecologists, nurses, and other skilled organizations have actively promoted awareness of urinary continence. The International Continence Society (ICS) has created the Continence Promotion Committee (CPC) to encourage public awareness programs, education, and services, about urinary incontinence globally. Thus, a growth in awareness programs regarding pelvic floor diseases and the increasing incidence of urinary incontinence (UI) by different government and non-profit organizations are fueling the pelvic floor stimulator industry.

Category-wise Insights

Why is the Demand for Electrical Stimulators Rising?

Segment Electrical Stimulators
Forecast CAGR (2023 to 2033) 9.1%

Electrical stimulators have a higher potential for growth in the coming years. The segment is likely to expand with a high CAGR of 9.1% in the coming decade. Electrical stimulation has appeared as one of the advanced and unique biofeedback types used for pelvic floor muscle rehabilitation.

The growing inclination to find a cost-effective and efficient pelvic floor exercise method with a rising focus on first-line conservative management programs for urinary incontinence in women is likely to fuel the adoption of electrical stimulators.

Are Urinary Incontinence Applications Expected to Continue Accounting for Maximum Sales?

The urinary incontinence segment is expected to contribute maximum revenue share in the global pelvic floor stimulators market. In terms of revenue, the urinary incontinence segment accounted for over 76% share in 2022.

Urinary incontinence is considered a significant health problem globally. It has a considerable economic and social impact on individuals and society. The rapid expansion of the geriatric population base is among the primary aspects leading to the increase in pelvic floor disorders.

As per estimates by the UNU (United Nations University), the percentage of the geriatric population above 65 is expected to rise to 16% by 2050 from 7% in 2000. Thus, the rising prevalence of urinary incontinence among elderly women in several regions has significantly driven the demand for pelvic floor stimulators.

What is the Scope of Growth for Distribution through Hospitals?

Segment Hospitals
Forecast CAGR (2023 to 2033) 9.2%

Hospitals are leading the market, with significant growth in the pelvic floor stimulators industry, with a 9.2% CAGR in the forecast period. Similarly, hospitals can impact higher investment abilities and capital with improved admittance to cutting-edge technologies and patient care, projected to enhance the market growth in the long term.

Manufacturers Spreading their Presence Worldwide by Expansions, Acquisitions, and New Launches

Manufacturers in the pelvic floor stimulators market are primarily aiming to carry out strategic collaborations while investing in research and development to consolidate growth in a competitive and fragmented market. Key players are also expanding their global and regional presence through product launches, acquisitions, expansions, and upgrading distribution channels to penetrate the pelvic floor stimulators industry.

  • For instance, in June 2021, Laborie Medical Technologies, and Urotronic Inc., announced the completion of the First Optilume procedures in the National Health Service (NHS), United Kingdom.
  • In March 2019, InControl Medical received FDA approval for the first over-the-counter (OTC) non-implantable muscle stimulator in the United States. It is intended for at-home use for women with stress, mixed bowel, or incontinence urinary incontinence.
  • In August 2020, Pelvital announced the FDA clearance for its Flyte intravaginal home-use device for the treatment of stress urinary incontinence patients.

Key Players in the Market

  • Medtronic Plc
  • Atlantic Therapeutics
  • Laborie Inc.
  • The Prometheus Group
  • Everyway Medical Instruments Co., Ltd.
  • KayCo 2 Ltd.
  • InControl Medical Ltd.
  • Tic Medizintechnik GmbH
  • Shenzhen XFT Medical Ltd.
  • Chiaro Technology Ltd.
  • Zynex Inc.
  • Utah Medical Products, Inc.
  • Verity Medical Ltd.

Scope of the Pelvic Floor Stimulators Market Report

Attribute Details
Pelvic Floor Stimulators Market Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Pelvic Floor Stimulators Industry Analysis US$ million for Value in million
Key Countries Covered The United States, Canada, the United Kingdom, Germany, Italy, France, Spain, Benelux, Russia, India, Thailand, Malaysia, Indonesia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, South Africa and North Africa
Key Segments Covered Product Type, Application, End User, and Region
Pelvic Floor Stimulators Market - Key Companies Profiled
  • Medtronic Plc
  • Atlantic Therapeutics
  • Laborie Inc.
  • The Prometheus Group
  • Everyway Medical Instruments Co., Ltd.
  • KayCo 2 Ltd.
  • InControl Medical Ltd.
  • Tic Medizintechnik GmbH
  • Shenzhen XFT Medical Ltd.
  • Chiaro Technology Ltd.
  • Zynex Inc.
  • Utah Medical Products, Inc.
  • Verity Medical Ltd.
Pelvic Floor Stimulators Market - Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Pelvic Floor Stimulators Industry by Category

Product Type:

  • Electrical stimulators
  • Magnetic Stimulators

Application:

  • Urinary Incontinence
  • Sexual Dysfunction
  • Neurodegenerative Diseases

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized clinics
  • Homecare setting

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

How did the Pelvic Floor Stimulators Market exhibit in the past?

The market boosted at a CAGR of 4.8% from 2018 to 2022.

What is the Pelvic Floor Stimulators Market Growth CAGR?

Through 2033, the market is to develop at a CAGR of 8.8%.

What will the Pelvic Stimulators Market size be in 2033?

By 2033, the market is to have expanded to US$ 325.41 million.

What is the momentary market valuation?

In 2023, the market is anticipated to reach a worth of US$ 140.39 million.

What proportion of the market is acquired by the United States?

The United States controls 76% of the North American market.

In India, what is the market share of Pelvic Floor Stimulator?

The Indian market accounts for more than 55% of all South Asian sales.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Electrical Stimulators

        5.3.2. Magnetic Stimulators

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Urinary Incontinence

        6.3.2. Sexual Dysfunction

        6.3.3. Neurodegenerative Diseases

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis by End-User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End-User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Specialized clinics

        7.3.4. Homecare setting

    7.4. Y-o-Y Growth Trend Analysis by End-User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis by End-User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East & Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Application

        9.2.4. By End-User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Application

        9.3.4. By End-User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Argentina

            10.2.1.4. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Application

        10.2.4. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Application

        10.3.4. By End-User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. United Kingdom

            11.2.1.2. Germany

            11.2.1.3. France

            11.2.1.4. Italy

            11.2.1.5. Spain

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Application

        11.2.4. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Application

        11.3.4. By End-User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Russia

            12.2.1.2. Poland

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Application

        12.2.4. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Application

        12.3.4. By End-User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product Type

        13.2.3. By Application

        13.2.4. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By End-User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product Type

        14.2.3. By Application

        14.2.4. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Application

        14.3.4. By End-User

    14.4. Key Takeaways

15. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. Iran

            15.2.1.2. Turkey

            15.2.1.3. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Application

        15.2.4. By End-User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Application

        15.3.4. By End-User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Application

            16.1.2.3. By End-User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Application

            16.2.2.3. By End-User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Application

            16.3.2.3. By End-User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Application

            16.4.2.3. By End-User

    16.5. Argentina

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Application

            16.5.2.3. By End-User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Application

            16.6.2.3. By End-User

    16.7. Germany

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Application

            16.7.2.3. By End-User

    16.8. France

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Application

            16.8.2.3. By End-User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Application

            16.9.2.3. By End-User

    16.10. Spain

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Application

            16.10.2.3. By End-User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Application

            16.11.2.3. By End-User

    16.12. Poland

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Application

            16.12.2.3. By End-User

    16.13. Czech Republic

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Application

            16.13.2.3. By End-User

    16.14. Romania

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Application

            16.14.2.3. By End-User

    16.15. India

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Application

            16.15.2.3. By End-User

    16.16. Bangladesh

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Application

            16.16.2.3. By End-User

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Application

            16.17.2.3. By End-User

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Application

            16.18.2.3. By End-User

    16.19. China

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Application

            16.19.2.3. By End-User

    16.20. Japan

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Application

            16.20.2.3. By End-User

    16.21. South Korea

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Application

            16.21.2.3. By End-User

    16.22. Iran

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product Type

            16.22.2.2. By Application

            16.22.2.3. By End-User

    16.23. Turkey

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product Type

            16.23.2.2. By Application

            16.23.2.3. By End-User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Application

        17.3.4. By End-User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Medtronic Plc

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Atlantic Therapeutics

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Laborie Inc.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. The Prometheus Group

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Everyway Medical Instruments Co., Ltd.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. KayCo 2 Ltd.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. InControl Medical Ltd.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Tic Medizintechnik GmbH

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Shenzhen XFT Medical Ltd.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Chiaro Technology Ltd.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. Zynex Inc.

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

        18.1.12. Utah Medical Products, Inc.

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

        18.1.13. Verity Medical Ltd.

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Female Pelvic Implants Market

Published : June 2023

Explore Healthcare Insights

View Reports

Pelvic Floor Stimulators Market